Evidence map›Paper›PMID 42755832›Full record

ArticleFrontiers in medicine2026

Impact of antiplatelet therapy on erectile dysfunction following percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

Joongwon Choi, Chung Un Lee, Hyun Woong Park, Jung Hoon Kim, Yong Seong Lee, Jong-Hwa Ahn, Jin Sin Koh, Min Gyu Kang, Weon Kim, Udaya S Tantry and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Joongwon Choi *Department of Urology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong and Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Chung Un Lee *Department of Urology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong and Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Hyun Woong ParkDivision of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
Jung Hoon KimDepartment of Urology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong and Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Yong Seong LeeDepartment of Urology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong and Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Jong-Hwa AhnDivision of Cardiology, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea.
Jin Sin KohDepartment of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Republic of Korea.
Min Gyu KangDepartment of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Republic of Korea.
Weon KimCardiovascular Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.
Udaya S TantrySinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Baltimore, MD, United States.
Paul A GurbelSinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Baltimore, MD, United States.
Jin-Yong HwangDepartment of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Republic of Korea.
Young-Hoon Jeong *CAU Thrombosis and Biomarker Center, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute myocardial infarction (AMI) is strongly associated with erectile dysfunction (ED). This study evaluated the association between P2Y Methods: The HEALING-AMI trial randomized patients with naïve ST-segment elevation myocardial infarction (STEMI) to dual antiplatelet therapy (DAPT) with either ticagrelor or clopidogrel. This substudy included 59 male patients who completed 6 months of DAPT (ticagrelor, Results: At 6-month follow-up, moderate-to-severe ED (IIEF-5 ≤ 11) and bleeding episodes (predominantly BARC type 1) were observed in 47.5% and 54.2%, respectively. Compared with clopidogrel, ticagrelor was associated with a lower IIEF-5 score (9.7 ± 8.8 vs. 17.0 ± 7.8, Conclusions: In male patients with STEMI, moderate-to-severe ED and bleeding episodes were common during DAPT. P2Y

Indexed as

antiplateletbleedingerectile dysfunctionmyocardial infarctionP2Y12 inhibitor

Identifiers

PMID42755832
PMCPMC13581904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.